Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis)

British Journal of Nutrition

Volumn 109, Issue 12, 2013, Pages 2199-2207

  Fung, Shing Tack ^a   Ho, Cyrus K ^a   Choi, Siu Wai ^a   Chung, Wai Yuen ^a   Benzie, Iris F F ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Antioxidants; Bioavailability; Biotransformation; Catechins; Epigallocatechin gallate; Green tea; Polyphenols

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; CONJUGATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; KIDNEY DISEASE; MALE; NONHUMAN; NORMAL HUMAN; TEA; URINALYSIS;

ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CAMELLIA SINENSIS; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

CAMELLIA SINENSIS;

EID: 84878395494     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004370     Document Type: Article

References (37)

1. Wang QM, Gong QY, Yan JJ, et al. (2010) Association between green tea intake and coronary artery disease in a Chinese population. Circ J 74, 294-300.
2. Khan N & Mukhtar H (2007) Tea polyphenols for health promotion. Life Sci 81, 519-533. (Pubitemid 47212236)
3. Yang CS, Lambert JD & Sang S (2009) Antioxidative and anticarcinogenic activities of tea polyphenols. Arch Toxicol 83, 11-21.
4. Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S-255S.
5. Higdon JV & Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43, 89-143. (Pubitemid 38552312)
6. Benzie IFF & Szeto YT (1999) Total antioxidant capacity of teas by the ferric reducing/antioxidant power (FRAP) assay. J Agric Food Chem 47, 633-637.
7. Benzie IFF, Szeto YT, Tomlinson B, et al. (1999) Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer 34, 83-87. (Pubitemid 29382920)
8. Lee MJ, Maliakal P, Chen L, et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomark Prev 11, 1025-1032. (Pubitemid 35192653)
9. Stalmach A, Troufflard S, Serafini M, et al. (2009) Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 53, S44-S53.
10. Del Rio D, Calani L, Cordero C, et al. (2010) Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition 26, 1110-1116.
11. Roowi S, Stalmach A, Mullen W, et al. (2010) Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem 58, 1296-1304.
12. Calani L, Del Rio D, Callegari L, et al. (2012) Updated bioavailability and 48h excretion profile of flavan-3-ols from green tea in humans. Int J Food Sci Nutr 63, 513-521.
13. Yang C, Chen L, Lee MJ, et al. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7, 351-354. (Pubitemid 28354149)
14. Russell W & Duthie G (2011) Plant secondary metabolites and gut health: the case for phenolic acids. Proc Nutr Soc 70, 389-396.
15. Chow HH, Cai Y, Hakim IA, et al. (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin Cancer Res 9, 3312-3319. (Pubitemid 37082725)
16. Müller N, Ellinger S, Alteheld B, et al. (2010) Bolus ingestion of white and green tea increases the concentration of several flavon-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. Mol Nutr Food Res 54, 1636-1645.
17. Renouf M, Guy P, Marmet C, et al. (2011) Plasma appearance and correlation between coffee and green tea metabolites in human subjects. Br J Nutr 104, 1635-1640.
18. Cordero C, Canale F, Del Rio D, et al. (2009) Identification, quantitation, and method validation for flavan-3-ols in fermented ready-to-drink teas from the Italian market using HPLC-UV/DAD and LC-MS/MS. J Sep Sci 32, 3643-3651.
19. Han KC, Wong WC & Benzie IFF (2011) Genoprotective effects of green tea (Camellia sinensis) in humans: results of a controlled supplementation trial. Br J Nutr 105, 171-179.
20. Jochmann N, Baumann G & Stangl V (2008) Green tea and cardiovascular disease: from molecular targets towards human health. Curr Opin Clin Nutr Metab Care 11, 758-765.
21. Lambert JD & Elias RJ (2010) The antioxidant and prooxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 50, 66-72.
22. Serafini M, Del Rio D, N'Dri YD, et al. (2011) Health benefits of tea. In Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed., pp. 239-262 [IFF Benzie and S Wachtel-Galor, editors]. Boca Raton, FL: CRC Press Taylor and Francis Group.
23. Brown AL, Lane J, Coverly J, et al. (2008) Effects of dietary supplementation with green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized trial. Br J Nutr 101, 886-894.
24. Westerterp-Plantenga MS (2010) Green tea catechins, caffeine and body-weight regulation. Physiol Behav 100, 42-46.
25. Nikaidou S, Ishizuka M, Maeda Y, et al. (2005) Effect of components of green tea extracts, caffeine and catechins on hepatic drug metabolizing enzyme activities and mutagenic transformation of carcinogens. Jpn J Vet Res 52, 185-192. (Pubitemid 40514537)
26. ITO EN (2012) Major components and health benefits of green tea. http://www.itoen.co.jp/eng/allabout-greentea/components-benefit/index.html (accessed August 2012).
27. Monagas M, Urpi-Sarda M, Sánchez-Patán F, et al. (2010) Insights into the metabolism and microbial transformation of dietary flavon-3-ols and the bioactivity of their metabolites. Food Funct 1, 233-253.
28. Del Rio D, Borges G & Crozier A (2010) Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104, Suppl. 3, S67-S90.
29. Williamson G & Clifford MN (2010) Colonic metabolites of berry polyphenols: the missing link to biological activity? Br J Nutr 104, Suppl. 3, S48-S66.
30. Benzie IFF & Wachtel-Galor S (2010) Vegetarian diets and public health: biomarker and redox connections. Antiox Redox Signal 13, 1575-1591.
31. Hou Z, Lambert JD, Chin K, et al. (2004) Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat Res 555, 3-19. (Pubitemid 39345394)
32. Fraga CS & Oteiza PI (2011) Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic Biol Med 51, 813-823.
33. Chu KO, Wang CC, Chu CY, et al. (2007) Uptake and distribution of catechins in fetal organs following in utero exposure in rats. Hum Reprod 22, 280-287. (Pubitemid 44942698)
34. Lambert JD, Lee MJ, Diamond L, et al. (2006) Dosedependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab Dispos 34, 8-11. (Pubitemid 43042639)
35. Wang P, Aronson WJ, Huang M, et al. (2010) Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev Res 3, 985-993.
36. Sang S, Lee MJ, Yang I, et al. (2008) Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Comm Mass Spectrom 22, 1567-1578. (Pubitemid 351829698)
37. Chow HH, Hakin IA, Vining DR, et al. (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11, 4627-4633. (Pubitemid 40825654)